V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023903 | 20010150 | 1.61 | null | Not known (9) | 2017-04-27 | 2017-05-12 | FEC + DOCETAXEL | N | N | 20084552 | FEC + DOCETAXEL |
| 20023904 | 20070849 | 1.63 | 56 | Adjuvant (A) | 2016-06-09 | 2016-06-09 | FEC 100 + DOCETAXEL | 02 | Y | 20084553 | FEC + DOCETAXEL |
| 20023905 | 20070849 | 1.6 | 81.6 | Not known (9) | 2015-04-21 | 2015-04-23 | FEC 100 + DOCETAXEL | 01 | N | 20084553 | FEC + DOCETAXEL |
| 20023906 | 20010151 | 1.76 | 85 | Not known (9) | 2014-01-08 | 2014-01-12 | FEC + DOCETAXEL | N | N | 20084567 | FEC + DOCETAXEL |
| 20023907 | 20010151 | 1.6 | 82.4 | Adjuvant (A) | 2015-01-05 | 2015-04-20 | FEC + DOCETAXEL | N | N | 20084567 | FEC + DOCETAXEL |
| 20023908 | 20108398 | null | 69 | Neo-adjuvant (N) | 2016-06-23 | 2016-06-30 | FEC + DOCETAXEL | 02 | N | 20084574 | FEC + DOCETAXEL |
| 20023909 | 20108398 | null | 84.7 | Neo-adjuvant (N) | 2015-07-25 | 2015-08-16 | FEC 100 + DOCETAXEL | N | N | 20084574 | FEC + DOCETAXEL |
| 20023910 | 20010152 | 1.72 | 68.2 | Neo-adjuvant (N) | 2014-05-04 | 2014-05-11 | FEC + DOCETAXEL | 02 | N | 20084581 | FEC + DOCETAXEL |
| 20023911 | 20010153 | 1.7 | 53.5 | Adjuvant (A) | null | 2017-12-05 | FEC + DOCETAXEL | N | N | 20084584 | FEC + DOCETAXEL |
| 20023912 | 20010153 | 1.72 | 64 | Palliative (P) | 2014-06-26 | 2014-06-26 | FEC + DOCETAXEL | 02 | null | 20084584 | FEC + DOCETAXEL |
| 20023913 | 20010153 | 1.69 | 52.9 | Adjuvant (A) | 2015-03-02 | 2015-03-04 | FEC 100 + DOCETAXEL | N | N | 20084584 | FEC + DOCETAXEL |
| 20023914 | 20010154 | null | 73.8 | Curative (C) | 2017-04-01 | 2017-04-01 | FEC + DOCETAXEL | 02 | N | 20084592 | FEC + DOCETAXEL |
| 20023915 | 20010154 | 1.62 | 91.3 | Adjuvant (A) | 2013-11-19 | 2013-11-20 | FEC + DOCETAXEL | 02 | N | 20084592 | FEC + DOCETAXEL |
| 20023916 | 20010155 | 1.67 | 59.6 | Adjuvant (A) | 2016-11-11 | 2016-11-12 | FEC + DOCETAXEL | 02 | N | 20084594 | FEC + DOCETAXEL |
| 20023917 | 20010155 | 1.65 | null | Neo-adjuvant (N) | 2014-02-18 | 2014-03-01 | FEC + DOCETAXEL | 2 | null | 20084594 | FEC + DOCETAXEL |
| 20023918 | 20010155 | 1.62 | 71.5 | Disease modification (D) | 2015-12-08 | 2015-12-09 | FEC + DOCETAXEL | 02 | N | 20084594 | FEC + DOCETAXEL |
| 20023919 | 20010156 | 1.64 | 95 | Adjuvant (A) | 2013-08-14 | 2013-08-28 | FEC + DOCETAXEL | N | N | 20084601 | FEC + DOCETAXEL |
| 20023920 | 20010156 | null | 73 | Not known (9) | 2013-06-08 | 2013-06-08 | FEC + DOCETAXEL | 02 | N | 20084601 | FEC + DOCETAXEL |
| 20023921 | 20010156 | 1.61 | 48.7 | Adjuvant (A) | 2017-01-09 | 2017-01-12 | FEC + DOCETAXEL | 2 | N | 20084601 | FEC + DOCETAXEL |
| 20023922 | 20010157 | 1.63 | 57.6 | Adjuvant (A) | 2014-11-09 | 2014-11-10 | FEC 100 + DOCETAXEL | 2 | null | 20084609 | FEC + DOCETAXEL |
| 20023923 | 20070855 | 1.24 | null | Neo-adjuvant (N) | 2015-09-19 | 2015-09-25 | FEC + DOCETAXEL | 99 | N | 20084610 | FEC + DOCETAXEL |
| 20023924 | 20010158 | 1.72 | 65.4 | Curative (C) | 2015-10-12 | 2015-09-17 | FEC 100 + DOCETAXEL | N | N | 20084617 | FEC + DOCETAXEL |
| 20023925 | 20010158 | 1.71 | 64 | Adjuvant (A) | 2013-04-16 | 2013-04-20 | FEC + DOCETAXEL | 2 | N | 20084617 | FEC + DOCETAXEL |
| 20023926 | 20010158 | 1.69 | 108 | Disease modification (D) | 2016-07-29 | 2016-07-31 | FEC + DOCETAXEL | 2 | N | 20084617 | FEC + DOCETAXEL |
| 20023927 | 20010158 | 1.67 | 65.7 | Adjuvant (A) | 2014-07-16 | 2014-07-29 | FEC + DOCETAXEL | 02 | N | 20084617 | FEC + DOCETAXEL |
| 20023928 | 20010159 | null | 68 | Adjuvant (A) | 2014-06-10 | 2014-06-30 | FEC + DOCETAXEL | N | N | 20084633 | FEC + DOCETAXEL |
| 20023929 | 20010159 | null | 85.7 | Adjuvant (A) | 2015-01-13 | 2015-01-23 | FEC + DOCETAXEL | null | null | 20084633 | FEC + DOCETAXEL |
| 20023930 | 20010159 | 1.66 | 68.4 | Adjuvant (A) | 2016-05-11 | 2016-05-25 | FEC 100 + DOCETAXEL | 2 | N | 20084633 | FEC + DOCETAXEL |
| 20023931 | 20010160 | 1.64 | 59 | Neo-adjuvant (N) | 2014-08-07 | 2014-08-11 | FEC + DOCETAXEL | 02 | N | 20084639 | FEC + DOCETAXEL |
| 20023932 | 20010160 | 1.72 | 79 | Not known (9) | 2017-02-06 | 2017-04-26 | FEC + DOCETAXEL | 02 | N | 20084639 | FEC + DOCETAXEL |
| 20023933 | 20010160 | null | null | Neo-adjuvant (N) | 2017-02-01 | 2017-02-24 | FEC 100 + DOCETAXEL | 2 | null | 20084639 | FEC + DOCETAXEL |
| 20023934 | 20127726 | 1.69 | 71.8 | Adjuvant (A) | 2018-04-17 | 2018-04-18 | FEC + DOCETAXEL | 02 | null | 20084642 | FEC + DOCETAXEL |
| 20023935 | 20127726 | 1.73 | 77 | Curative (C) | 2014-07-25 | 2014-07-25 | null | 2 | N | 20084642 | FEC + DOCETAXEL |
| 20023936 | 20010161 | 1.64 | 100 | Adjuvant (A) | 2017-08-02 | 2017-08-10 | FEC + DOCETAXEL | 02 | N | 20084644 | FEC + DOCETAXEL |
| 20023937 | 20010161 | null | null | Curative (C) | 2013-08-15 | 2013-09-08 | FEC + DOCETAXEL | 02 | null | 20084644 | FEC + DOCETAXEL |
| 20023938 | 20010162 | 1.75 | 57.4 | Curative (C) | 2017-04-14 | 2017-04-26 | FEC + DOCETAXEL | 02 | null | 20084648 | FEC + DOCETAXEL |
| 20023939 | 20070860 | 1.59 | 81.6 | Neo-adjuvant (N) | 2013-04-12 | 2013-04-14 | FEC + DOCETAXEL | 02 | N | 20084652 | FEC + DOCETAXEL |
| 20023940 | 20010163 | 1.79 | 55.2 | Adjuvant (A) | 2017-10-10 | 2017-10-23 | FEC 100 + DOCETAXEL | 02 | N | 20084655 | FEC + DOCETAXEL |
| 20023941 | 20010163 | 1.55 | 85.5 | Neo-adjuvant (N) | 2017-07-01 | 2017-07-01 | FEC 100 + DOCETAXEL | 02 | N | 20084655 | FEC + DOCETAXEL |
| 20023942 | 20010164 | 1.6 | 68.3 | Adjuvant (A) | 2013-11-19 | 2013-11-19 | FEC + DOCETAXEL | 02 | N | 20084664 | FEC + DOCETAXEL |
| 20023943 | 20010165 | 1.65 | 58 | Adjuvant (A) | 2016-07-29 | 2016-08-11 | FEC + DOCETAXEL | 02 | N | 20084665 | FEC + DOCETAXEL |
| 20023944 | 20010165 | 1.63 | 75.3 | Adjuvant (A) | null | 2017-01-30 | FEC + DOCETAXEL | N | N | 20084665 | FEC + DOCETAXEL |
| 20023945 | 20108405 | 1.73 | 87.4 | Curative (C) | 2018-02-20 | 2018-03-08 | FEC + DOCETAXEL | N | N | 20084672 | FEC + DOCETAXEL |
| 20023946 | 20127727 | 1.65 | 76.6 | Adjuvant (A) | 2013-11-01 | 2013-11-01 | FEC 100 + DOCETAXEL | 02 | N | 20084674 | FEC + DOCETAXEL |
| 20023947 | 20010166 | null | 94.9 | null | 2018-01-16 | 2018-02-07 | FEC + DOCETAXEL | N | N | 20084675 | FEC + DOCETAXEL |
| 20023948 | 20010166 | 1.65 | 64.6 | Adjuvant (A) | 2015-07-03 | 2015-07-23 | FEC + DOCETAXEL | 02 | N | 20084675 | FEC + DOCETAXEL |
| 20023949 | 20010167 | 1.6 | 67.5 | Adjuvant (A) | 2016-11-14 | 2016-11-14 | FEC + DOCETAXEL | 2 | N | 20084684 | FEC + DOCETAXEL |
| 20023950 | 20010168 | 1.62 | 84.8 | Adjuvant (A) | 2015-11-02 | 2015-11-02 | FEC + DOCETAXEL | 02 | N | 20084686 | FEC + DOCETAXEL |
| 20023951 | 20010168 | 1.66 | 61.7 | Adjuvant (A) | 2016-08-01 | 2016-08-16 | FEC 100 + DOCETAXEL | null | N | 20084686 | FEC + DOCETAXEL |
| 20023952 | 20010169 | 1.62 | 96 | Curative (C) | 2016-05-28 | 2016-05-28 | FEC + DOCETAXEL | 02 | N | 20084698 | FEC + DOCETAXEL |